News | April 11, 2022
New very-high-sensitivity rapid antigen test kits hit Australian market
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Supply increase to help meet growing global demand
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
The money will be donated to the United Nations Children’s Fund (UNICEF)
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The agreement follows positive NICE recommendation and commits to deliver Leqvio (inclisiran) access via a population health management approach identifying eligible patients across England
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
Subscribe To Our Newsletter & Stay Updated
